Skip to content
AwardedSpainGoods€326,074

Suministro de los productos farmacéuticos (Momelotinib y Sotorasib), para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.

Published
Published 27 June 2025

Overview

La justificación de adquisición de los productos farmacéuticos Momelotinib y Sotorasib, se basa en atender las necesidades de abastecimiento del Complejo.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€326,074
Procedure
Direct
Published
27 June 2025
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€371,771
Award date
26 May 2025
Winners
  • AMGEN S.A.
  • GLAXOSMITHKLINE, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    30 June 2025

  2. Contract Award Notice

    27 June 2025

Contracting authority

  • Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21063710150131

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de los productos farmacéuticos (Momelotinib y Sotorasib), para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria. — won by AMGEN S.A. +1 — Skim